nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.042	0.251	CbGbCtD
Ropinirole—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0335	0.2	CbGbCtD
Ropinirole—HTR1D—meninx—peripheral nervous system neoplasm	0.0231	0.128	CbGeAlD
Ropinirole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.022	0.131	CbGbCtD
Ropinirole—HTR1B—dura mater—peripheral nervous system neoplasm	0.022	0.122	CbGeAlD
Ropinirole—HTR1D—dura mater—peripheral nervous system neoplasm	0.0213	0.118	CbGeAlD
Ropinirole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0204	0.122	CbGbCtD
Ropinirole—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0164	0.098	CbGbCtD
Ropinirole—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0124	0.0691	CbGeAlD
Ropinirole—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.00945	0.0525	CbGeAlD
Ropinirole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00938	0.056	CbGbCtD
Ropinirole—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00922	0.0551	CbGbCtD
Ropinirole—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.00915	0.0508	CbGeAlD
Ropinirole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0086	0.0514	CbGbCtD
Ropinirole—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00673	0.0374	CbGeAlD
Ropinirole—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00652	0.0362	CbGeAlD
Ropinirole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00586	0.035	CbGbCtD
Ropinirole—DRD5—ganglion—peripheral nervous system neoplasm	0.0055	0.0306	CbGeAlD
Ropinirole—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00454	0.0253	CbGeAlD
Ropinirole—DRD1—nerve—peripheral nervous system neoplasm	0.00426	0.0237	CbGeAlD
Ropinirole—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00425	0.0236	CbGeAlD
Ropinirole—DRD1—ganglion—peripheral nervous system neoplasm	0.0042	0.0234	CbGeAlD
Ropinirole—HTR1B—ganglion—peripheral nervous system neoplasm	0.00341	0.0189	CbGeAlD
Ropinirole—HTR1D—ganglion—peripheral nervous system neoplasm	0.0033	0.0183	CbGeAlD
Ropinirole—HTR2C—ganglion—peripheral nervous system neoplasm	0.00327	0.0182	CbGeAlD
Ropinirole—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00324	0.018	CbGeAlD
Ropinirole—HTR2A—pons—peripheral nervous system neoplasm	0.0032	0.0178	CbGeAlD
Ropinirole—HTR1A—ganglion—peripheral nervous system neoplasm	0.00275	0.0153	CbGeAlD
Ropinirole—DRD2—nerve—peripheral nervous system neoplasm	0.00252	0.014	CbGeAlD
Ropinirole—DRD2—ganglion—peripheral nervous system neoplasm	0.00248	0.0138	CbGeAlD
Ropinirole—DRD1—brainstem—peripheral nervous system neoplasm	0.00183	0.0102	CbGeAlD
Ropinirole—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00167	0.0093	CbGeAlD
Ropinirole—HTR2A—nerve—peripheral nervous system neoplasm	0.00166	0.00922	CbGeAlD
Ropinirole—HTR2A—ganglion—peripheral nervous system neoplasm	0.00164	0.00911	CbGeAlD
Ropinirole—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00162	0.00901	CbGeAlD
Ropinirole—HTR1B—brainstem—peripheral nervous system neoplasm	0.00148	0.00823	CbGeAlD
Ropinirole—HTR1D—brainstem—peripheral nervous system neoplasm	0.00143	0.00797	CbGeAlD
Ropinirole—HTR2C—brainstem—peripheral nervous system neoplasm	0.00142	0.00789	CbGeAlD
Ropinirole—HTR1A—brainstem—peripheral nervous system neoplasm	0.0012	0.00664	CbGeAlD
Ropinirole—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.00119	0.00659	CbGeAlD
Ropinirole—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.00112	0.00622	CbGeAlD
Ropinirole—DRD2—brainstem—peripheral nervous system neoplasm	0.00108	0.006	CbGeAlD
Ropinirole—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000947	0.00526	CbGeAlD
Ropinirole—HTR2A—brainstem—peripheral nervous system neoplasm	0.000712	0.00396	CbGeAlD
Ropinirole—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000649	0.00361	CbGeAlD
Ropinirole—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000589	0.00328	CbGeAlD
Ropinirole—DRD2—cerebellum—peripheral nervous system neoplasm	0.000532	0.00296	CbGeAlD
Ropinirole—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000518	0.00288	CbGeAlD
Ropinirole—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000413	0.0023	CbGeAlD
Ropinirole—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000351	0.00195	CbGeAlD
Ropinirole—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.00032	0.00178	CbGeAlD
Ropinirole—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000104	0.000175	CcSEcCtD
Ropinirole—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000175	CcSEcCtD
Ropinirole—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000174	CcSEcCtD
Ropinirole—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000174	CcSEcCtD
Ropinirole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000103	0.000174	CcSEcCtD
Ropinirole—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000173	CcSEcCtD
Ropinirole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000173	CcSEcCtD
Ropinirole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000102	0.000172	CcSEcCtD
Ropinirole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000102	0.000172	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000102	0.000171	CcSEcCtD
Ropinirole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000101	0.000171	CcSEcCtD
Ropinirole—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000101	0.00017	CcSEcCtD
Ropinirole—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00017	CcSEcCtD
Ropinirole—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000169	CcSEcCtD
Ropinirole—Pain—Etoposide—peripheral nervous system neoplasm	0.000101	0.000169	CcSEcCtD
Ropinirole—Constipation—Etoposide—peripheral nervous system neoplasm	0.000101	0.000169	CcSEcCtD
Ropinirole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000169	CcSEcCtD
Ropinirole—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000169	CcSEcCtD
Ropinirole—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000169	CcSEcCtD
Ropinirole—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	9.97e-05	0.000168	CcSEcCtD
Ropinirole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.96e-05	0.000167	CcSEcCtD
Ropinirole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.93e-05	0.000167	CcSEcCtD
Ropinirole—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	9.91e-05	0.000167	CcSEcCtD
Ropinirole—Haematuria—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000166	CcSEcCtD
Ropinirole—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	9.79e-05	0.000165	CcSEcCtD
Ropinirole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	9.78e-05	0.000164	CcSEcCtD
Ropinirole—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000164	CcSEcCtD
Ropinirole—Epistaxis—Epirubicin—peripheral nervous system neoplasm	9.75e-05	0.000164	CcSEcCtD
Ropinirole—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	9.7e-05	0.000163	CcSEcCtD
Ropinirole—Sinusitis—Epirubicin—peripheral nervous system neoplasm	9.7e-05	0.000163	CcSEcCtD
Ropinirole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.69e-05	0.000163	CcSEcCtD
Ropinirole—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	9.68e-05	0.000163	CcSEcCtD
Ropinirole—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.65e-05	0.000162	CcSEcCtD
Ropinirole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	9.65e-05	0.000162	CcSEcCtD
Ropinirole—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	9.62e-05	0.000162	CcSEcCtD
Ropinirole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.62e-05	0.000162	CcSEcCtD
Ropinirole—Dizziness—Vincristine—peripheral nervous system neoplasm	9.6e-05	0.000161	CcSEcCtD
Ropinirole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.58e-05	0.000161	CcSEcCtD
Ropinirole—Infestation—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.000161	CcSEcCtD
Ropinirole—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.000161	CcSEcCtD
Ropinirole—Rash—Alitretinoin—peripheral nervous system neoplasm	9.5e-05	0.00016	CcSEcCtD
Ropinirole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.49e-05	0.00016	CcSEcCtD
Ropinirole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.46e-05	0.000159	CcSEcCtD
Ropinirole—Bradycardia—Epirubicin—peripheral nervous system neoplasm	9.45e-05	0.000159	CcSEcCtD
Ropinirole—Headache—Alitretinoin—peripheral nervous system neoplasm	9.44e-05	0.000159	CcSEcCtD
Ropinirole—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000158	CcSEcCtD
Ropinirole—Urticaria—Etoposide—peripheral nervous system neoplasm	9.34e-05	0.000157	CcSEcCtD
Ropinirole—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	9.33e-05	0.000157	CcSEcCtD
Ropinirole—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	9.32e-05	0.000157	CcSEcCtD
Ropinirole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	9.3e-05	0.000156	CcSEcCtD
Ropinirole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	9.3e-05	0.000156	CcSEcCtD
Ropinirole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	9.3e-05	0.000156	CcSEcCtD
Ropinirole—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	9.3e-05	0.000156	CcSEcCtD
Ropinirole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	9.3e-05	0.000156	CcSEcCtD
Ropinirole—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000156	CcSEcCtD
Ropinirole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	9.23e-05	0.000155	CcSEcCtD
Ropinirole—Vomiting—Vincristine—peripheral nervous system neoplasm	9.23e-05	0.000155	CcSEcCtD
Ropinirole—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.21e-05	0.000155	CcSEcCtD
Ropinirole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000155	CcSEcCtD
Ropinirole—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	9.16e-05	0.000154	CcSEcCtD
Ropinirole—Rash—Vincristine—peripheral nervous system neoplasm	9.15e-05	0.000154	CcSEcCtD
Ropinirole—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.15e-05	0.000154	CcSEcCtD
Ropinirole—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	9.14e-05	0.000154	CcSEcCtD
Ropinirole—Haematuria—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.000153	CcSEcCtD
Ropinirole—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	9.12e-05	0.000153	CcSEcCtD
Ropinirole—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000153	CcSEcCtD
Ropinirole—Headache—Vincristine—peripheral nervous system neoplasm	9.1e-05	0.000153	CcSEcCtD
Ropinirole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	9.05e-05	0.000152	CcSEcCtD
Ropinirole—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	9.02e-05	0.000152	CcSEcCtD
Ropinirole—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.000151	CcSEcCtD
Ropinirole—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.95e-05	0.00015	CcSEcCtD
Ropinirole—Visual impairment—Epirubicin—peripheral nervous system neoplasm	8.94e-05	0.00015	CcSEcCtD
Ropinirole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	8.93e-05	0.00015	CcSEcCtD
Ropinirole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.78e-05	0.000148	CcSEcCtD
Ropinirole—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	8.74e-05	0.000147	CcSEcCtD
Ropinirole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	8.67e-05	0.000146	CcSEcCtD
Ropinirole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.67e-05	0.000146	CcSEcCtD
Ropinirole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	8.65e-05	0.000145	CcSEcCtD
Ropinirole—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	8.63e-05	0.000145	CcSEcCtD
Ropinirole—Nausea—Vincristine—peripheral nervous system neoplasm	8.62e-05	0.000145	CcSEcCtD
Ropinirole—Flushing—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000145	CcSEcCtD
Ropinirole—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000145	CcSEcCtD
Ropinirole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000145	CcSEcCtD
Ropinirole—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000144	CcSEcCtD
Ropinirole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	8.54e-05	0.000144	CcSEcCtD
Ropinirole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000143	CcSEcCtD
Ropinirole—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.000143	CcSEcCtD
Ropinirole—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	8.46e-05	0.000142	CcSEcCtD
Ropinirole—Asthenia—Etoposide—peripheral nervous system neoplasm	8.44e-05	0.000142	CcSEcCtD
Ropinirole—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	8.44e-05	0.000142	CcSEcCtD
Ropinirole—Angiopathy—Epirubicin—peripheral nervous system neoplasm	8.42e-05	0.000142	CcSEcCtD
Ropinirole—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000141	CcSEcCtD
Ropinirole—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	8.38e-05	0.000141	CcSEcCtD
Ropinirole—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.000141	CcSEcCtD
Ropinirole—Chills—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.00014	CcSEcCtD
Ropinirole—Pruritus—Etoposide—peripheral nervous system neoplasm	8.32e-05	0.00014	CcSEcCtD
Ropinirole—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	8.29e-05	0.000139	CcSEcCtD
Ropinirole—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	8.27e-05	0.000139	CcSEcCtD
Ropinirole—Alopecia—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000138	CcSEcCtD
Ropinirole—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.16e-05	0.000137	CcSEcCtD
Ropinirole—Mental disorder—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000137	CcSEcCtD
Ropinirole—Rash—Cisplatin—peripheral nervous system neoplasm	8.09e-05	0.000136	CcSEcCtD
Ropinirole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.09e-05	0.000136	CcSEcCtD
Ropinirole—Malnutrition—Epirubicin—peripheral nervous system neoplasm	8.08e-05	0.000136	CcSEcCtD
Ropinirole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.05e-05	0.000135	CcSEcCtD
Ropinirole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	8.02e-05	0.000135	CcSEcCtD
Ropinirole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	8.01e-05	0.000135	CcSEcCtD
Ropinirole—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000134	CcSEcCtD
Ropinirole—Flushing—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000134	CcSEcCtD
Ropinirole—Flatulence—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000134	CcSEcCtD
Ropinirole—Tension—Epirubicin—peripheral nervous system neoplasm	7.93e-05	0.000133	CcSEcCtD
Ropinirole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.000133	CcSEcCtD
Ropinirole—Nervousness—Epirubicin—peripheral nervous system neoplasm	7.85e-05	0.000132	CcSEcCtD
Ropinirole—Back pain—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000131	CcSEcCtD
Ropinirole—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.79e-05	0.000131	CcSEcCtD
Ropinirole—Dizziness—Etoposide—peripheral nervous system neoplasm	7.78e-05	0.000131	CcSEcCtD
Ropinirole—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.77e-05	0.000131	CcSEcCtD
Ropinirole—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.00013	CcSEcCtD
Ropinirole—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.00013	CcSEcCtD
Ropinirole—Chills—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.00013	CcSEcCtD
Ropinirole—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000129	CcSEcCtD
Ropinirole—Nausea—Cisplatin—peripheral nervous system neoplasm	7.63e-05	0.000128	CcSEcCtD
Ropinirole—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.61e-05	0.000128	CcSEcCtD
Ropinirole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000128	CcSEcCtD
Ropinirole—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000126	CcSEcCtD
Ropinirole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	7.5e-05	0.000126	CcSEcCtD
Ropinirole—Vomiting—Etoposide—peripheral nervous system neoplasm	7.48e-05	0.000126	CcSEcCtD
Ropinirole—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000126	CcSEcCtD
Ropinirole—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.47e-05	0.000126	CcSEcCtD
Ropinirole—Agitation—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.000125	CcSEcCtD
Ropinirole—Rash—Etoposide—peripheral nervous system neoplasm	7.42e-05	0.000125	CcSEcCtD
Ropinirole—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.41e-05	0.000125	CcSEcCtD
Ropinirole—Headache—Etoposide—peripheral nervous system neoplasm	7.37e-05	0.000124	CcSEcCtD
Ropinirole—Flatulence—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000124	CcSEcCtD
Ropinirole—Tension—Doxorubicin—peripheral nervous system neoplasm	7.33e-05	0.000123	CcSEcCtD
Ropinirole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000123	CcSEcCtD
Ropinirole—Malaise—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000122	CcSEcCtD
Ropinirole—Nervousness—Doxorubicin—peripheral nervous system neoplasm	7.26e-05	0.000122	CcSEcCtD
Ropinirole—Vertigo—Epirubicin—peripheral nervous system neoplasm	7.26e-05	0.000122	CcSEcCtD
Ropinirole—Syncope—Epirubicin—peripheral nervous system neoplasm	7.24e-05	0.000122	CcSEcCtD
Ropinirole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000122	CcSEcCtD
Ropinirole—Back pain—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000122	CcSEcCtD
Ropinirole—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	7.19e-05	0.000121	CcSEcCtD
Ropinirole—Palpitations—Epirubicin—peripheral nervous system neoplasm	7.14e-05	0.00012	CcSEcCtD
Ropinirole—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	7.1e-05	0.000119	CcSEcCtD
Ropinirole—Cough—Epirubicin—peripheral nervous system neoplasm	7.05e-05	0.000118	CcSEcCtD
Ropinirole—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	7.04e-05	0.000118	CcSEcCtD
Ropinirole—Convulsion—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000118	CcSEcCtD
Ropinirole—Nausea—Etoposide—peripheral nervous system neoplasm	6.99e-05	0.000117	CcSEcCtD
Ropinirole—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000117	CcSEcCtD
Ropinirole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.94e-05	0.000117	CcSEcCtD
Ropinirole—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000116	CcSEcCtD
Ropinirole—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000116	CcSEcCtD
Ropinirole—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000116	CcSEcCtD
Ropinirole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000116	CcSEcCtD
Ropinirole—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000115	CcSEcCtD
Ropinirole—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.000115	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.000115	CcSEcCtD
Ropinirole—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000114	CcSEcCtD
Ropinirole—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.74e-05	0.000113	CcSEcCtD
Ropinirole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	6.73e-05	0.000113	CcSEcCtD
Ropinirole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.72e-05	0.000113	CcSEcCtD
Ropinirole—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.7e-05	0.000113	CcSEcCtD
Ropinirole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000112	CcSEcCtD
Ropinirole—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.000112	CcSEcCtD
Ropinirole—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.000111	CcSEcCtD
Ropinirole—Oedema—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.000111	CcSEcCtD
Ropinirole—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.57e-05	0.00011	CcSEcCtD
Ropinirole—Infection—Epirubicin—peripheral nervous system neoplasm	6.55e-05	0.00011	CcSEcCtD
Ropinirole—Cough—Doxorubicin—peripheral nervous system neoplasm	6.52e-05	0.00011	CcSEcCtD
Ropinirole—Shock—Epirubicin—peripheral nervous system neoplasm	6.49e-05	0.000109	CcSEcCtD
Ropinirole—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000109	CcSEcCtD
Ropinirole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.47e-05	0.000109	CcSEcCtD
Ropinirole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000109	CcSEcCtD
Ropinirole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000108	CcSEcCtD
Ropinirole—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000108	CcSEcCtD
Ropinirole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.000108	CcSEcCtD
Ropinirole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000107	CcSEcCtD
Ropinirole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000107	CcSEcCtD
Ropinirole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000107	CcSEcCtD
Ropinirole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000107	CcSEcCtD
Ropinirole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000107	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000106	CcSEcCtD
Ropinirole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000106	CcSEcCtD
Ropinirole—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000106	CcSEcCtD
Ropinirole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000105	CcSEcCtD
Ropinirole—Hypotension—Epirubicin—peripheral nervous system neoplasm	6.16e-05	0.000104	CcSEcCtD
Ropinirole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.15e-05	0.000103	CcSEcCtD
Ropinirole—Oedema—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000103	CcSEcCtD
Ropinirole—Infection—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000102	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.000101	CcSEcCtD
Ropinirole—Shock—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.000101	CcSEcCtD
Ropinirole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.000101	CcSEcCtD
Ropinirole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.97e-05	0.0001	CcSEcCtD
Ropinirole—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.0001	CcSEcCtD
Ropinirole—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.0001	CcSEcCtD
Ropinirole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	9.96e-05	CcSEcCtD
Ropinirole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.92e-05	9.95e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	9.91e-05	CcSEcCtD
Ropinirole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.88e-05	9.88e-05	CcSEcCtD
Ropinirole—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.86e-05	9.85e-05	CcSEcCtD
Ropinirole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	9.77e-05	CcSEcCtD
Ropinirole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.8e-05	9.76e-05	CcSEcCtD
Ropinirole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.73e-05	9.63e-05	CcSEcCtD
Ropinirole—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	9.58e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.69e-05	9.57e-05	CcSEcCtD
Ropinirole—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.68e-05	9.55e-05	CcSEcCtD
Ropinirole—Pain—Epirubicin—peripheral nervous system neoplasm	5.64e-05	9.48e-05	CcSEcCtD
Ropinirole—Constipation—Epirubicin—peripheral nervous system neoplasm	5.64e-05	9.48e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	9.34e-05	CcSEcCtD
Ropinirole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	9.27e-05	CcSEcCtD
Ropinirole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	9.21e-05	CcSEcCtD
Ropinirole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	9.14e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.43e-05	9.13e-05	CcSEcCtD
Ropinirole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.42e-05	9.12e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.39e-05	9.06e-05	CcSEcCtD
Ropinirole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	9.03e-05	CcSEcCtD
Ropinirole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.3e-05	8.91e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	8.85e-05	CcSEcCtD
Ropinirole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	8.84e-05	CcSEcCtD
Ropinirole—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.24e-05	8.8e-05	CcSEcCtD
Ropinirole—Pain—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	8.77e-05	CcSEcCtD
Ropinirole—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	8.77e-05	CcSEcCtD
Ropinirole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.21e-05	8.76e-05	CcSEcCtD
Ropinirole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.21e-05	8.76e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	8.45e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.99e-05	8.39e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.86e-05	8.16e-05	CcSEcCtD
Ropinirole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	8.15e-05	CcSEcCtD
Ropinirole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	8.11e-05	CcSEcCtD
Ropinirole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	8.11e-05	CcSEcCtD
Ropinirole—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.73e-05	7.95e-05	CcSEcCtD
Ropinirole—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.66e-05	7.84e-05	CcSEcCtD
Ropinirole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.51e-05	7.58e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	7.55e-05	CcSEcCtD
Ropinirole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	7.36e-05	CcSEcCtD
Ropinirole—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.36e-05	7.33e-05	CcSEcCtD
Ropinirole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	7.25e-05	CcSEcCtD
Ropinirole—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.19e-05	7.05e-05	CcSEcCtD
Ropinirole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	7.02e-05	CcSEcCtD
Ropinirole—Rash—Epirubicin—peripheral nervous system neoplasm	4.16e-05	6.99e-05	CcSEcCtD
Ropinirole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.15e-05	6.98e-05	CcSEcCtD
Ropinirole—Headache—Epirubicin—peripheral nervous system neoplasm	4.13e-05	6.94e-05	CcSEcCtD
Ropinirole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	6.78e-05	CcSEcCtD
Ropinirole—Nausea—Epirubicin—peripheral nervous system neoplasm	3.92e-05	6.58e-05	CcSEcCtD
Ropinirole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	6.52e-05	CcSEcCtD
Ropinirole—Rash—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	6.47e-05	CcSEcCtD
Ropinirole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	6.46e-05	CcSEcCtD
Ropinirole—Headache—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	6.42e-05	CcSEcCtD
Ropinirole—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.62e-05	6.09e-05	CcSEcCtD
Ropinirole—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	2.41e-05	0.000417	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.38e-05	0.000412	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.36e-05	0.000408	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.35e-05	0.000406	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	2.33e-05	0.000403	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	2.32e-05	0.000401	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.32e-05	0.000401	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.31e-05	0.000401	CbGpPWpGaD
Ropinirole—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.31e-05	0.0004	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—NRAS—peripheral nervous system neoplasm	2.27e-05	0.000393	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.25e-05	0.00039	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.24e-05	0.000387	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.23e-05	0.000387	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.23e-05	0.000385	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.22e-05	0.000385	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.21e-05	0.000383	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—GNAS—peripheral nervous system neoplasm	2.2e-05	0.000381	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.2e-05	0.00038	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	2.19e-05	0.000379	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.18e-05	0.000378	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.18e-05	0.000377	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.17e-05	0.000375	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.16e-05	0.000375	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—ABCB1—peripheral nervous system neoplasm	2.16e-05	0.000374	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.15e-05	0.000372	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.11e-05	0.000364	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.07e-05	0.000359	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.06e-05	0.000357	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.01e-05	0.000347	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2e-05	0.000346	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.97e-05	0.000341	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.97e-05	0.00034	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.94e-05	0.000336	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.93e-05	0.000335	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.91e-05	0.000331	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.9e-05	0.000329	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.89e-05	0.000328	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.88e-05	0.000325	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.86e-05	0.000322	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	1.86e-05	0.000322	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.84e-05	0.000319	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.84e-05	0.000319	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.83e-05	0.000317	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.82e-05	0.000315	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.8e-05	0.000312	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.8e-05	0.000311	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.79e-05	0.00031	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.79e-05	0.00031	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	1.79e-05	0.00031	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	1.78e-05	0.000308	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.77e-05	0.000307	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.77e-05	0.000306	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.76e-05	0.000304	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	1.75e-05	0.000304	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.74e-05	0.000301	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	1.74e-05	0.0003	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.74e-05	0.0003	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.72e-05	0.000298	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.71e-05	0.000296	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.71e-05	0.000296	CbGpPWpGaD
Ropinirole—DRD5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.68e-05	0.00029	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.67e-05	0.000289	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.66e-05	0.000287	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	1.66e-05	0.000287	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.66e-05	0.000287	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.64e-05	0.000285	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.63e-05	0.000282	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.63e-05	0.000282	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	1.57e-05	0.000272	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.56e-05	0.000271	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.54e-05	0.000267	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.54e-05	0.000266	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.52e-05	0.000263	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.52e-05	0.000263	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.52e-05	0.000263	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.52e-05	0.000263	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.5e-05	0.000259	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	1.47e-05	0.000254	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.45e-05	0.000251	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.43e-05	0.000247	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	1.41e-05	0.000244	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.4e-05	0.000242	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.39e-05	0.000241	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.39e-05	0.000241	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.37e-05	0.000237	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.37e-05	0.000237	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.35e-05	0.000234	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.35e-05	0.000233	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.35e-05	0.000233	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.34e-05	0.000232	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.32e-05	0.000229	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.32e-05	0.000228	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.32e-05	0.000228	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.3e-05	0.000225	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.3e-05	0.000224	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.29e-05	0.000224	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.29e-05	0.000223	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.29e-05	0.000223	CbGpPWpGaD
Ropinirole—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.28e-05	0.000222	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.28e-05	0.000221	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.27e-05	0.00022	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.27e-05	0.00022	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.26e-05	0.000218	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.25e-05	0.000216	CbGpPWpGaD
Ropinirole—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000214	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.23e-05	0.000212	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.23e-05	0.000212	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.22e-05	0.00021	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.21e-05	0.00021	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.21e-05	0.000209	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.2e-05	0.000208	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.19e-05	0.000206	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.18e-05	0.000205	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.18e-05	0.000204	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.17e-05	0.000203	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.17e-05	0.000202	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.17e-05	0.000202	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.17e-05	0.000202	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.16e-05	0.000201	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.16e-05	0.000201	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.14e-05	0.000198	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.14e-05	0.000198	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.14e-05	0.000198	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.14e-05	0.000198	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.13e-05	0.000196	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.12e-05	0.000194	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.11e-05	0.000193	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.1e-05	0.000191	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.1e-05	0.00019	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.09e-05	0.000188	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.08e-05	0.000187	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000186	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.07e-05	0.000184	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.06e-05	0.000184	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.06e-05	0.000183	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.04e-05	0.000181	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.04e-05	0.000181	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.04e-05	0.00018	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.04e-05	0.00018	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.03e-05	0.000178	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.02e-05	0.000177	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.02e-05	0.000176	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.01e-05	0.000175	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.01e-05	0.000175	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.97e-06	0.000173	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.93e-06	0.000172	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	9.93e-06	0.000172	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.92e-06	0.000172	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	9.87e-06	0.000171	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.85e-06	0.00017	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.83e-06	0.00017	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.8e-06	0.00017	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.79e-06	0.00017	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.72e-06	0.000168	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.69e-06	0.000168	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.57e-06	0.000166	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.57e-06	0.000166	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.53e-06	0.000165	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.52e-06	0.000165	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.48e-06	0.000164	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.47e-06	0.000164	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.44e-06	0.000163	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	9.33e-06	0.000162	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.26e-06	0.00016	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.24e-06	0.00016	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.18e-06	0.000159	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.17e-06	0.000159	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.13e-06	0.000158	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.12e-06	0.000158	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.03e-06	0.000156	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.01e-06	0.000156	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.99e-06	0.000156	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.69e-06	0.00015	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.65e-06	0.00015	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.64e-06	0.00015	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.61e-06	0.000149	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.51e-06	0.000147	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.5e-06	0.000147	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.41e-06	0.000146	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.41e-06	0.000145	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.33e-06	0.000144	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.27e-06	0.000143	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.24e-06	0.000143	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.21e-06	0.000142	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.19e-06	0.000142	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.15e-06	0.000141	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.98e-06	0.000138	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.95e-06	0.000138	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.91e-06	0.000137	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.86e-06	0.000136	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.8e-06	0.000135	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.74e-06	0.000134	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.69e-06	0.000133	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.67e-06	0.000133	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.63e-06	0.000132	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.63e-06	0.000132	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	7.62e-06	0.000132	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.52e-06	0.00013	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.51e-06	0.00013	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.51e-06	0.00013	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.5e-06	0.00013	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	7.48e-06	0.000129	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.45e-06	0.000129	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.41e-06	0.000128	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.37e-06	0.000128	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.17e-06	0.000124	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.17e-06	0.000124	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.07e-06	0.000122	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.98e-06	0.000121	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.98e-06	0.000121	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.88e-06	0.000119	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.87e-06	0.000119	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.83e-06	0.000118	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.76e-06	0.000117	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.74e-06	0.000117	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.67e-06	0.000116	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.63e-06	0.000115	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.5e-06	0.000113	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.4e-06	0.000111	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.33e-06	0.00011	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.3e-06	0.000109	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.25e-06	0.000108	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.08e-06	0.000105	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.05e-06	0.000105	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.02e-06	0.000104	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.97e-06	0.000103	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	5.94e-06	0.000103	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.89e-06	0.000102	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.88e-06	0.000102	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.82e-06	0.000101	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.82e-06	0.000101	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.79e-06	0.0001	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.63e-06	9.74e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.34e-06	9.24e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.32e-06	9.21e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.25e-06	9.09e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.14e-06	8.89e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.11e-06	8.84e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.11e-06	8.84e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.02e-06	8.7e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.97e-06	8.6e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	4.83e-06	8.36e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.78e-06	8.27e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.57e-06	7.91e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.51e-06	7.8e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.44e-06	7.68e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.04e-06	6.99e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	3.15e-06	5.44e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.66e-06	4.61e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.06e-06	3.56e-05	CbGpPWpGaD
